Breast cancer testing: What is appropriate?

Journal of Surgical Oncology

Volumn 81, Issue 3, 2002, Pages 111-112

  Lind, D Scott ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST CANCER; CANCER EPIDEMIOLOGY; CANCER SCREENING; CANCER TEST; COMPUTER ASSISTED TOMOGRAPHY; EDITORIAL; PRACTICE GUIDELINE; PRIORITY JOURNAL; RECURRENT CANCER;

BONE AND BONES; BREAST NEOPLASMS; FEMALE; HUMANS; MAMMOGRAPHY; NEOPLASM STAGING; UNNECESSARY PROCEDURES;

EID: 0036829935     PISSN: 00224790     EISSN: None     Source Type: Journal    
DOI: 10.1002/jso.10167     Document Type: Editorial

References (5)

1. Hanna W: Testing for HER2 status. Oncology 2001;61(Suppl 2):22-30.
2. Giuliano AE: Current status of sentinel lymphadenectomy in breast cancer. Ann Surg Oncol 2001;8(Suppl 9):52S-55S.
3. Murphy KC, Coppin CML, Kader HEHA, et al.: Follow-up after treatment for breast cancer. Can Med Assoc J 1998;158(Suppl 3):S65-S70.
4. Loprinzi CL, Hayes D, Smith T: Doc, shouldn't we be getting some tests? J Clin Oncol 2000;18(11):2345-2348.
5. Smith TJ, David NE, Schapira DV, et al.: American Society of Clinical Oncology 1998 update of recommended breast cancer surveillance guidelines. J Clin Oncol 1999;47:1080-1082.